Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Income towards Parent Company (2021 - 2026)

Alvotech's (ALVO) quarterly Income towards Parent Company came in at -$66.7 million in Q2 2026, down 397.12% on a YoY basis from $22.5 million in Q2 2025, and down 7181.0% quarter-over-quarter from $942000.0 in Q1 2026.

Analysis

Alvotech (ALVO) Income towards Parent Company (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Income towards Parent Company for 6 consecutive years, with -$66.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income towards Parent Company fell 397.12% year-over-year to -$66.7 million; the trailing twelve-month figure through Jun 2026 stood at -$278.7 million (down 56.91% YoY), and the FY2025 full-year result was $244.8 million, up 220.42% from the prior year.
  • Income towards Parent Company slipped to -$66.7 million in Q2 2026 per ALVO's latest filing, from $942000.0 in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $405.2 million in Q2 2022 and bottomed at -$750.4 million in Q1 2023.
  • Historically, Income towards Parent Company has averaged -$169.1 million across 5 years, with a median of -$126.6 million in 2023.
  • The widest YoY moves for Income towards Parent Company: up 133.32% in 2025, down 626.08% in 2025.
  • Over 5 years, Income towards Parent Company stood at -$568.7 million in 2022, then slipped by 20.15% to -$683.3 million in 2023, then surged by 70.25% to -$203.3 million in 2024, then surged by 131.36% to $63.7 million in 2025, then plunged by 204.64% to -$66.7 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$66.7 million, $942000.0, and $63.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -66.70 Mn
Mar 31, 2026 942,000.00
Dec 31, 2025 63.74 Mn
Sep 30, 2025 -276.69 Mn
Jun 30, 2025 -13.42 Mn
Mar 31, 2025 77.16 Mn
Dec 31, 2024 -203.26 Mn
Sep 30, 2024 -38.11 Mn
Jun 30, 2024 88.37 Mn
Mar 31, 2024 -231.61 Mn
Dec 31, 2023 -683.29 Mn
Aug 31, 2023 -186.56 Mn
Jun 30, 2023 148.38 Mn
Mar 20, 2023 -750.37 Mn
Dec 31, 2022 -568.72 Mn
Aug 31, 2022 -218.62 Mn
Jun 30, 2022 405.24 Mn
Mar 20, 2022 -589.71 Mn
Dec 31, 2021 -148.94 Mn
Sep 30, 2021 -125.39 Mn